A monocyte product with interleukin 1 receptor antagonist (I~LRa) activity has recently been isohted, cloned, and sequenced (1) . Considerable interest has been generated by this molecule in view of its ability to block the prolnfl~ruma-tory activities of II.1 both in vitro and in vivo (2, 3) . Most studies have shown that monocytes, along with leukemia monocytic cell lines, produce this molecule after activation by a variety of stimuli. Although one report has suggested that neutrophils may also secrete products with 11.1 inhibitory activity (4) , no molecular characterization of this activity has yet been performed. It therefore remains unknown if neutrophils produce an 11.1 inhibitor similar to that made by monocytes.
In recent years, studies from our laboratory have focused on investigating de novo protein synthesis and secretion by neutrophils after activation by proinflammatory molecules (5) (6) (7) . In the context of these studies, we have observed that a limited number of neutrophil agonists can mediate the nuclear-signaling events necessary to induce de novo RNA synthesis in this cell type (8) . Of a wide range of stimuli investigated, only three were found to induce significant RNA synthesis in neutrophils. These are GM-CSF, TNF-ol, and the formyhted oligopeptide FMLP. H~, only the former two agonists were capable of inducing the synthesis and secretion ofa 23-kD protein, the nature of which was not identified at the time of our initial studies (9) . We now report that this protein has the same molecular characteristics as the Ib 1Ra produced by monocytes. We also report that of de novo synthesized and secreted proteins by neutrophils, IL-1Ra is the major product in response to stimulation by GM-CSF and TNF-c~.
Materials and Methods

Reagents.
The following molecules used in this study were generous gifts from the Genetics Institute (Boston, MA): recombinant human (rh)GM-CSF, rhlL-3, rhIL-4, and rhIL-6, rhTGF/~ and rh platelet-derived growth factorbb (PDGFbb) were purchased from Collaborative Research (Bedford, MA) and Bachem Fine Chemicals (Torrance, CA), respectively, whereas rhG-CSF was purchased from R & D Systems, Inc. (Minneapolis, MN). rhTNF-ol was a gift from Knoll Pharmaceuticals (Whippany, NJ) and rhIFN-3, was purchased from Chemicon International, Inc. (Temecula, CA). rhIL-l~ was a generous gift from Genentech Inc. (San Francisco, CA) and rhID8 was purchased from Upstate Biotechnology Inc. (Lake Placid, NY). The formylated oligopeptide FMLP, rhC5a, and platelet-activating factor (PAF) were purchased from Sigma Chemical Co. (St. Louis, MO). Leukotriene B4 (LTB4) was generously provided by Merck-Frosst Canada (Dorval, Quebec, Canada). The endotoxin LPS was purchased from Gibco Laboratories (Burlington, Ontario, Canada).
[3SS]Methionine, [3SS]cysteine, and [3zP]deoxycytidine triphosphate were purchased from Amersham (Oakville, ON, Canada). All other reagents were of molecular biological grade and were purchased from the Sigma Chemical Co.
Neutropkil Isolation. Neutrophils were isolated from venous blood obtained from normal healthy volunteers and synovial fluid of patients with rheumatoid arthritis as previously described (5, 6) . All neutrophil preparations contained <0.2% monocytes as determined by nonspecific monoesterase staining. Viability was estimated by the trypan blue dye exclusion procedure and found to be >99% in all preparations.
Metabolic Labeling of Neutrophih. The neutrophils were suspended at a density of 10S/ml in methionine-and cysteine-free RPMI 1640. Labeling was performed in the presence of 0.1% FCS with [3SS]methionine (1,000 Ci/mmol) and [3sS]cysteine (1,300 Ci/mmol), at a concentration of 125/zCi/ml for each hbel incubated at 37~ for various time periods as specified in the relevant figure legends.
lmmunoisolation oflLIRa. Cell culture supernatants were processed for immunoisolation using two different sources of antibodies directed against IL-1Ra: (a) a cocktail ofmAbs to IL-1Ra, a generous gift from Dr. Ann Berger (The Upjohn Co., Kalamazoo, MI); and (b) a polyclonal rabbit antibody to IL-1Ra, a generous gift from Dr. WiLliam Arend (University of Colorado School of Medicine, Denver, CO). Immunoisolation was carried out according to the procedure of Davis et al. (10) .
RNA Isolation and Northern Blotting. Isolation of total cellular
RNA and Northern blots were performed as previously described (5) . The IblRa cDNA probe used for these studies, a 1.8-kb fragment cloned into the EcoRI site of a PGEM2 plasmid, was a generous gift of Dr. Daniel E. Tracey (Upjohn Co.) (11) .
Quantitative Measurement of ILIRa. The measurement of II~ 1Ra was performed using an ELISA purchased from R & D Systems, Inc. This immunoassay was performed as specified by the manufacturer. Statistical analyses were performed using the student's t test.
Results
Production of lLIRa by Neutrophils. Neutrophils were stimulated with a number of known neutrophil agonists in the presence of [3SS]methionine and [3SS]cysteine in order to study the effects of each agonist on the induction of de novo protein synthesis and secretion. SDS-PAGE was then performed on the incubation media obtained from treated and untreated neutrophils. It was observed that of all the agonists used in this study, only GM-CSF and TNF-o~ induced the synthesis and secretion of a 23-kD molecule by neutrophils. A fluorogram obtained from a typical experiment in which neutrophils were stimulated with either GM-CSF or TNF-c~ is shown in Fig. 1 . The proteins secreted from nonactivated neutrophils are shown in Fig. 1 , lane A, whereas those obtained from GM-CSF-and TNF-ol-stimulated neutrophils are shown in Fig. 1 , lanes B and D, respectively. Although neither GM-CSF nor TNF-oe significantly altered general protein synthesis in neutrophils, it can be clearly seen that the intensity of the 23-kD band, along with two slightly lower molecular mass bands, was significantly enhanced. The optimal concentrations for the induction of this synthesis were 3 nM for GM-CSF and 1,000 U/ml for TNF-ot. Optimal stimulating and labeling periods were 4 h. It was also observed that the use of a minimum of 0.1% FCS in the incubation media was sufficient for optimal induction of synthesis by GM-CSF and TNF-o~ (results not shown). Using a polyclonal antibody to IL,1Ra, the 23-kD band along with the two lower molecular mass bands were immunostained both from the GM-CSF, and the TNF-cc-stimulated cells (Fig. 1 , lanes C and E, respectively). Similar results were obtained when using a cocktail of mAbs to IL-1Ra for immunoisolation. However, under the same conditions, neither II, lc~ nor II--13 was detected using specific mAbs directed against these two antigens (data not shown). The various stimuli used in this study are shown in Table 1 . For each neutrophil agonist, a dose-response course was performed using concentrations ranging from sub-to supraoptimal levels as defined in other systems. Furthermore, time course studies over a 24-h period were also performed with each agonist.
Northern blot hybridization studies were also performed using a cDNA probe for IL-1Ra in order to measure levels 
Neutrophits were activated with the agonists and metabolically labeled as described (see Materials and Methods). Cell supernatants were then analyzed by SDS-PAGE for the presence of de novo synthesized IL-1Ka. Experiments were repeated with cells isolated from the Peripheral blood of at least six normal individuals.
of IL-1Ra mKNA in neutrophils. Kesults are shown in Fig.  2 , where it can be seen that the levels of mKNA were considerably increased in GM-CSF-and TNF-o~-activated cells (Fig. 2 , lanes 2 and 3, respectively) over control cells (Fig.  2 , lane I), with a more pronounced effect after GM-CSF activation. With a longer exposure time, a 1.9-kb band was also observed in unstimulated cells. Fig. 2 , bottom, shows the photograph of the ethidium bromide-stained gel. It reveals the integrity of the RNA preparations along with a comparison of the total amounts loaded on the gel. were performed. Densitometric scanning of SDS-PAGE performed with cell lysates revealed that the level de novo synthesized intracellular IblKa was maximal at 1 h (data not shown), while secretion was maximal at 4 h (Fig 3 A) . Similar analyses performed on Northern blots (Fig. 3 B) showed increased levels of IL-1Ra mKNA as early as 0.5 h, reaching a peak at 1 h. At 24 h, no IbRa mKNA was detectable in neutrophils, indicating significant degradation at this point in time.
Kinetics of Induction of lL.IRa mRNA Accumulation, and IIJ 1Ra Synthesis and Secretion by Neutrophils after GM-CSF and TNF-ot
Measurement of ll.,1Ra Production by Neutrophils.
We next measured the intra-and extracellular levels of IIARa using nonactivated and activated neutrophils. IblRa was measured by ELISA using cells isolated from three normal individuals, and the results are expressed in nanograms per milliliter/106 neutrophils. As can be seen from Table 2 , there was an eightfold excess of intracellular over extraceUular IblRa in nonactivated cells and a four-to fivefold excess in activated cells, implying that the great majority of newly synthesized IblRa was being secreted. The differences between nonactivated and activated neutrophils with respect to intraceUular 1D1Ra levels were not statistically significant. In contrast, activated ceils secreted significantly higher levels of IL-1Ra than did nonactivated cells (iv <0.007 for GM-CSF and iv <0.001 for TNFc 0. We next investigated whether the increased extracellular levels of IblRa observed after activation were due to increased de novo synthesis of this molecule as opposed to increased secretion ofintracdlular IL-1Ra content. To address this question, we activated neutrophils with GM-CSF and TNF-oe in the presence or absence of the protein synthesis inhibitor, cycloheximide. The results presented in Table 2 show that extracdlular IL-1Ra, after activation with either GM-CSF or TNF-oe, was markedly decreased by cycloheximide (p <0.006), whereas intraceUular levels were found not to be significantly affected.
Level of lL.1Ra Production by Neutroivhils Relative to Other De Novo Synthesized and Secreted Proteins. Upon visual in-
spection of the fluorograms presented in Fig. 1 , it can be observed that relative to the other products represented by the various bands seen on the fluorogram, IblRa appears as the major de novo synthesized and secreted neutrophil product in response to either GM-CSF or TNF-c~. To further illustrate this, densitometric scanning studies were performed on the fluorograms shown in Fig. 1, lanes A, B, clearly seen that IL-1Ra (the 23-kD band) is by far the major component of all de novo synthesized and secreted products of activated neutrophils. This is particularly evident in GM-CSF-activated cells.
Production of lL1Ra by Neutrophils Isolated from the Synovial Fluid of Patients with Rheumatoid Arthritis.
We next wanted to determine whether neutrophils isolated from an inflammatory milieu retained their ability to synthesize and secrete IL-1Ra in response to stimulation by GM-CSF and TNF-ol. To perform this study, we used neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis. Neutrophils were stimulated and metabolically labeled as described above. Immunoisolation of IblRa from cell supernatants was then performed using the polydonal antibody to IL-1Re. Results are presented in Fig. 5 A, where it can be seen that there is an induction of de novo synthesis and secretion of IL-1Ra after GM-CSF (Fig. 5 A, lane 2) and TNF-c~ (Fig.  5 A, lane 3 ) stimulation compared with nonactivated cells (Fig. 5 A, lane 1) . Northern blots were also performed using RNA isolated from these cells and hybridized with the IL1Ra eDNA probe. The results presented in Fig. 5 B show that levels of mlLNA in neutrophils are increased after GM-CSF (Fig. 5 B, lane 2) and TNF-ol (Fig. 5 B, lane 3) stimulation when compared with nonactivated ceils (Fig. 5 B, lane   I ). Fig. 5 B, bottom, shows a photograph of the ethidium bromide-stained gel used for the Northern blot.
Discussion
We have previously shown that GM-CSF and TNF-ol induce the de novo synthesis and secretion of a 23-kD protein by neutrophils in a highly sdective manner (9) . In the present study, we have characterized this product as the IL-1Ra.
Measurement of the amounts of IL-1Ra associated with cell lysates and supernatants of neutrophils leads us to suggest that the contribution of neutrophils to the production of IblRa may be substantial when compared with that by macrophages. A recent study quantified IblRa production induced by GM-CSF in in vitro derived macrophages using ELISA (12) . Measurements were reported as the quantity (ng/ml) product by 0.83 x 106 macrophages. Under these conditions, ~40 ng/ml of IL-1Ra was associated with the cell lysates and 10 ng/ml was detected in the cell supernatants. Although it may be inappropriate to compare our results (4-h incubation of neutrophils) with those of that study using 7-d macrophage cultures, our measurements would indicate that macrophages produce ~20 times more IL-1Ra. If one is to take the example of synovial fluid from patients with rheumatoid arthritis, where neutrophils can outnumber macrophages by a factor of at least 20, it can be concluded that in the presence of GM-CSF (or TNF-cx), production of II.-ltLa by neutrophils may equal that by macrophages.
Studies on de novo protein synthesis by neutrophils must always consider the possibility of a contribution by small numbers of contaminating monocytes. We have estimated that monocytes produce "~20 times more IblRa than neutrophils. Our neutrophil preparations would therefore have to be contaminated by a minimum of 5% monocytes to account for all of the IL-1Ka that was measured. By nonspecific monoesterase staining, contaminating monocytes never exceeded 0.2%.
It has been shown that IblRe must be in excess of Ibl to inhibit the stimulatory effects of this cytoldne (13) . It therefore makes physiological sense that neutrophils would produce the amounts of IL-1Ra that they do. When analyzing the results of a recent study that measured II.-1 production by neutrophils using conditions that are highly similar to those used in this study (14) , comparisons between IL-I~ and IL-1Ra production by neutrophils can be made. After 4 h of stimulation by TNF-o~, the cell-associated IDII3 per 106 cells was ,v15 pg/ml, whereas we measured 2 ng/ml of IL-1ga, a 130-fold excess. Again under the same conditions, the levels of secreted IL-113 was ,v5 vs. 500 pg/ml for IL-1ga, a 100-fold excess.
We also observed that of the de novo protein synthesis and secretion by neutrophils in response to activation by GM-CSF and TNP-ol, IL-1Ra constitutes by far the major protein. Therefore, in terms of quantity alone, production of IL-1Ra by neutrophils is a major event in response to this type of activation. This obviously raises the issue of the biological significance for the need of neutrophils to mount this relatively massive response in terms of IL-1tLa production. Studies performed in vitro on the sfimulatory effects of IL-1 on neutrophils have yielded conflicting results (15) (16) (17) and will have to await further investigation before any firm conclusions can be made. Interestingly, however, IL-1 injected into animals leads to the accumulation of neutrophils at the site of injection (18) , and in vivo studies on the use of IL-1Ka have shown that it reduces the number of tissue-invading neutrophils in septic shock (3). This latter finding would be in agreement with the observation that IL-1ga reduces IL-1-induced adhesion of neutrophils to endothelial cells (11) . In this context, production of relatively large amounts of IL-1Ra by neutrophils at inflammatory sites could be of major biological significance.
